| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014175 Producting proteases which differ from wild type in at least one amino acid for use in industrial and food applications such as textile treatment, detergents and protein degradation |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014170 Controlling formation of acidic sugar chain associated with heterologously expressed glycoproteins in pichia; preparing less antigenic polypeptides; pharmacology; drug design |
| 01/22/2004 | US20040014156 Comprises immunoglobulin which binds and can be utilized to determine concentration and/or accelerate clearance of polyethylene glycol containing compound; monitoring cell toxicity; immunotherapy; antitumor agents |
| 01/22/2004 | US20040014145 Monoclonal antibody with affinity to defective transferrin for diagnosing alcoholism; immunoassay |
| 01/22/2004 | US20040014136 Crystal structure of complement inhibitor (sCR1) for preventing hemolysis, necrosis and tissue destruction |
| 01/22/2004 | US20040014134 Two coloured fluorimetric protease assay |
| 01/22/2004 | US20040014132 Comprises immunoglobulins which binds and neutralizes chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens |
| 01/22/2004 | US20040014130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014085 Design of unpaired forward and reverse primers having homology to 5' end of one template and to the 3' end of another template; genetic engineering |
| 01/22/2004 | US20040014071 Non-radioactive markers that facilitate the detection and analysis of nascent proteins translated within cellular or cell-free systems; preferred markers are dipyrrometheneboron difluoride |
| 01/22/2004 | US20040014058 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014039 Nucleic acids, proteins, and antibodies |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040014024 Use of stable cell lines genetically engineered to express a recombinant fibroblast growth factor receptor (FGFR) |
| 01/22/2004 | US20040013790 Dehulling sesame seeds, coarsely grinding while still wet in the presence of water/alcohol mixture to extract oil, then decanting |
| 01/22/2004 | US20040013686 Surface exposure epitope of loops of Neisseria; induction antibodies; competitive binding |
| 01/22/2004 | US20040013677 Mixtures; for therapy, prevention; purity polypeptide |
| 01/22/2004 | US20040013673 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013607 Conjugated to Y-90 through aminohexyl diethylenetriaminepentaacetic acid chelating agent |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2492649A1 Therapies for renal failure using interferon-.beta. |
| 01/22/2004 | CA2492267A1 Methods and media for controlling sialylation of proteins produced by mammalian cells |
| 01/22/2004 | CA2490976A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 01/21/2004 | EP1382679A2 Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP1382348A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 01/21/2004 | EP1381866A2 Process for differential diagnosis of alzheimer's dementia and device therefor |
| 01/21/2004 | EP1381678A2 Nucleic acid modification enzymes |
| 01/21/2004 | EP1381677A2 Neurotoxins with enhanced target specificity |
| 01/21/2004 | EP1381675A2 Method for replicating the hepatitis c virus |
| 01/21/2004 | EP1381631A2 Human timp-1 antibodies |
| 01/21/2004 | EP1381630A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381628A2 Inflammation-specific peptides and the uses thereof |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381625A1 Mutants of green fluorescent protein |
| 01/21/2004 | EP1381623A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/21/2004 | EP1381388A1 Production of peptides in plants as n-terminal viral coat protein fusions |
| 01/21/2004 | EP1381345A2 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 01/21/2004 | EP1381280A1 Viral vectors and their use in therapeutic methods |
| 01/21/2004 | EP0830376B1 Process for producing erythropoietin containing no animal proteins |
| 01/21/2004 | EP0822260B1 Substance fa-70d, process for producing the same, and uses thereof |
| 01/21/2004 | EP0734263B1 ALPHAvBETA3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS |
| 01/21/2004 | CN1469930A Cytomegalovirus intron a fragments |
| 01/21/2004 | CN1469929A Method of modifying microorganism-origin transglutaminase |
| 01/21/2004 | CN1468963A Construction and application of gene engineering strain of Harpin protein expressing colibacillus |
| 01/21/2004 | CN1468960A Production process of human lysozyme as AIDS treating medicine with plant as bioreactor |
| 01/21/2004 | CN1468953A High-efficiency expression in Pichia yeast, fermentation and purification of human gamma-interferon |
| 01/21/2004 | CN1468865A Fusion protein of recombinant SARS virus N protein carboxyl terminal peptide section and GST and its prepn |
| 01/21/2004 | CN1468862A Technological process of producing recombinant human histiotype plasminogen activator TNK mutant |
| 01/21/2004 | CN1468861A Recombinant human immune deficiency virus fusion inhibitor and its prepn and use |
| 01/21/2004 | CN1135267C Method for preparing soybean polypeptide by enzyme process |
| 01/21/2004 | CN1135266C Process for preparing Low-molecular peptide with sodium caseinate as raw material and equipment thereof |
| 01/21/2004 | CN1135235C Method for extracting prion protein and reagent kit |
| 01/20/2004 | US6680424 Modified proteinase inhibitors |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/20/2004 | US6680189 (a disintegrin and metalloprotease) adam proteins; preventing or treating disc herniation, ischialgia, glomerular nephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis or osteoporosis |
| 01/20/2004 | US6680181 Production of peptides |
| 01/20/2004 | US6680179 Host/vector system for expression of membrane proteins |
| 01/20/2004 | US6680175 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 01/20/2004 | US6680171 Drug screening, genetic engineering |
| 01/20/2004 | US6680060 A live hepatitis a virus adapted to growth in mrc-5 cells (human fibroblast-like cell line) |
| 01/20/2004 | US6680053 Variable region of the monoclonal antibody against the HBV S-surface antigen and a gene encoding the same |
| 01/20/2004 | US6678998 Floral packaging material having great masters prints thereon |
| 01/20/2004 | CA2148599C Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them |
| 01/20/2004 | CA2101534C Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 01/20/2004 | CA2090961C Specific binding agents |
| 01/15/2004 | WO2004005538A1 Method of screening anticancer agent |
| 01/15/2004 | WO2004005512A1 Nove protein and use thereof |
| 01/15/2004 | WO2004005503A1 Milk-coagulating enzyme originating in bacterium and process for producing cheese using the same |
| 01/15/2004 | WO2004005480A2 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | WO2004005473A2 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | WO2004005337A1 Phosphoinositolglycan (pig)-binding protein from adipocytes |
| 01/15/2004 | WO2004005292A1 Novel antibiotics against vibrio anguillarum and the applications thereof in cultures of fish, crustaceans, molluscs and other aquaculture activities |
| 01/15/2004 | WO2004005221A2 Benzoate- and anthranilate-inducible promoters |
| 01/15/2004 | WO2003090513A3 Bi-specific antigen-binding compositions and related methods |
| 01/15/2004 | WO2003063783A3 Multiple virus replicon culture systems |
| 01/15/2004 | WO2003060072A3 Recombinant polypeptides |
| 01/15/2004 | WO2003059260A3 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 01/15/2004 | WO2003046557A3 Hp biopolymer markers predictive of insulin resistance |
| 01/15/2004 | WO2003045995A3 Cell culture process |
| 01/15/2004 | WO2003040169A3 Human monoclonal antibodies to dendritic cells |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002078526A3 Cancer-testis antigens |
| 01/15/2004 | WO2002072607A3 Soluble heterodimeric cytokine receptor |
| 01/15/2004 | WO2002060935A8 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/15/2004 | WO2002046364A8 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/15/2004 | WO2002042777A3 Modulation of the interaction between evh1 domains |
| 01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
| 01/15/2004 | US20040010810 Producing xenogeneic monocolnal antibody for diagnosis and treatment of cancer, inflammation, allergies and asthma, autoimmune and cardiovascular diseases; immunotherapy |